MO
Matt O'Brien Piper Sandler Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
42
Avg Return
Past Year
Past Year
0.08%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
90.9%
Neutral
9.1%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Health Information Services
Medical Devices
Medical Distribution
Medical Instruments & Supplies
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Reiterated
| $115 |
23%
upside
| 1 | +14% |
0
%
| 8 Jan ‘26 10 days ago |
|
|
|
Overweight
Maintained
| $30 |
31%
upside
| 1 | -0.98% |
0
%
| 12 Dec ‘25 1 month ago |
|
|
|
Neutral
Reiterated
| $1.25 |
23%
upside
| 1 | -22% |
–
| 14 Nov ‘25 2 months ago |
|
|
|
Overweight
Reiterated
| $18 |
29%
upside
| 1 | +6.1% |
0
%
| 12 Nov ‘25 2 months ago |
|
|
|
Overweight
Maintained
| $55 |
32%
upside
| 1 | -8.9% |
0
%
| 6 Nov ‘25 2 months ago |
|
|
|
Overweight
Reiterated
| $50 |
65%
upside
| 1 | -18% |
0
%
| 5 Nov ‘25 2 months ago |
|
|
|
Overweight
Maintained
| $75 |
8%
upside
| 1 | +1.8% |
0
%
| 31 Oct ‘25 2 months ago |
|
|
|
Overweight
Reiterated
| $25 |
41%
upside
| 1 | +19% |
0
%
| 31 Oct ‘25 2 months ago |
|
|
|
Overweight
Maintained
| $140 |
2%
downside
| 1 | +13% |
0
%
| 30 Oct ‘25 2 months ago |
|
|
|
Overweight
Reiterated
| $32 |
73%
upside
| 1 | -2.9% |
0
%
| 29 Oct ‘25 2 months ago |
|
|
|
Overweight
Maintained
| $82 |
4%
downside
| 1 | +16% |
0
%
| 24 Oct ‘25 2 months ago |
|